| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |